Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
1998-09-09
2001-02-20
Carlson, Karen Cochrane (Department: 1653)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S325000, C435S252300, C435S348000, C435S006120, C536S023100, C530S350000
Reexamination Certificate
active
06190882
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of molecular genetics and neuroendocrine cellular biology. More specifically, the present invention relates to a mammalian drosophila period-like gene that exhibits properties of a circadian pacemaker.
2. Description of the Related Art
In response to daily environmental cues, the physiology and behavior of all living organisms from bacteria to humans are controlled by circadian rhythms driven by endogenous oscillators (Dunlap, 1993, Takahashi, 1995). Alteration of the circadian rhythm in humans can lead to behavioral changes as typified by jet lag and sleep disorders including those associated with shift work (Arendt and Broadway, 1987, Vignau et al., 1993, Wehr, 1996). In addition, certain pathophysiologies are known to fluctuate according to circadian rhythms such as the increased likelihood of a myocardial infarction occurring in the morning, and winter seasonal affective disorder (Kraft and Martin, 1995, Swaab et al., 1996, Teicher et al., 1997).
Extensive physiological and behavioral studies have determined that the endogenous clock is characterized by a cycle approximately 24 hours in duration. When organisms are placed under invariant environmental conditions, this clock is self-sustaining, similar to a pacemaker. This endogenous clock is further distinguished by its ability to be entrained, i.e., synchronized by environmental cues such as light and temperature cycles (Pittendrigh, 1993, Takahashi, 1995).
Primary culture of suprachiasmatic nucleus (SCN) neurons and suprachiasmatic nucleus ablation and transplantation studies indicate that the circadian clock is cell autonomous, and that in mammals it is located primarily in a part of the hypothalamus known as the suprachiasmatic nucleus, (Ralph et al., 1990, Welsh et al., 1995) and is situated close to the base of the brain. There are independent circadian oscillators located in the retina (Tosini and Menaker, 1996). In constant darkness, the various circadian functions such as maintenance of body temperature, formation of urine, and secretion of cortisol become asynchronous (Aschoff, 1969). This suggests that there may be several independent clocks that each regulate specific circadian rhythms. However, studies of the hamster tau mutant suggest that the molecular components that constitute the various clocks may be related (Tosini and Menaker, 1996).
The molecular mechanisms that constitute these oscillators in mammals are unknown. 2-deoxy [
14
C]-glucose uptake experiments (Schwartz and Gainer, 1977) and studies using protein and RNA synthesis inhibitors suggest that circadian rhythms can be controlled by periodic expression of genes (Takahashi and Turek, 1987, Raju et al., 1991). A mutation in a single gene, clock, alters the phase of the circadian clocks in mice (King et al., 1997). Whether clock is expressed in a periodic pattern is not known.
In Drosophila, two genes period (per) and timeless (tim), are essential components of the circadian clock (Reppert and Sauman, 1995). A heterodimer of Per and Tim proteins is thought to regulate the circadian process by creating a negative feedback loop controlling per and tim expression (Zeng et al., 1996). Two lines of evidence, the oscillatory nature of the per expression, and the phenotype of per mutants, portray the central role of the per gene in the circadian machinery of insects (Konopka and Benzer, 1971, Citri et al., 1987, Hardin et al., 1990, Hall, 1996). Immunohistochemical analysis of rat brain using a Drosophila Per antibody revealed staining in the suprachiasmatic nucleus, suggesting the possibility of a conserved mammalian Per protein (Siwicki et al., 1992). However, in over a decade since per was first isolated from
Drosophila melanogaster
(Bargellow et al., 1984; Citri et al., 1987), no mammalian per homologue has yet been reported.
The prior art is deficient in the lack of a mammalian ortholog to the drosophila period gene that exhibits properties of a circadian pacemaker. The present invention fulfills this longstanding need and desire in the art.
SUMMARY OF THE INVENTION
The molecular components of mammalian circadian clocks were previously unknown. The present invention demonstrates the isolation of a human gene termed RIGUI that encodes a basic-helix-loop-helix motif/PAS protein 44% homologous (identical amino acids, conservative and neutral substitutions) to
Drosophila period.
The highly conserved mouse homolog (m-rigui) is expressed in a circadian pattern in the suprachiasmatic nucleus (SCN), the neuroanotomical site of circadian regulation in mammals. Circadian expression in the suprachiasmatic nucleus continues in constant darkness, and a shift in the light/dark cycle evokes a proportional shift of m-rigui expression in the suprachiasmatic nucleus. m-rigui transcripts also appear in a circadian pattern in Purkinje neurons, pars tuberalis, and retina, but with a timing of oscillation different from that seen in the suprachiasmatic nucleus. Sequence homology and circadian patterns of expression suggest that RIGUI is a mammalian ortholog of the
Drosophila period
gene, raising the possibility that a regulator of circadian clocks is conserved.
In one embodiment of the present invention, there is provided a DNA encoding a RIGUI protein selected from the group consisting of: (a) isolated DNA which encodes a RIGUI protein; (b) isolated DNA which hybridizes to isolated DNA of (a) above and which encodes a RIGUI protein; and (c) isolated DNA differing from the isolated DNAs of (a) and (b) above in codon sequence due to the degeneracy of the genetic code, and which encodes a RIGUI protein.
In another embodiment of the present invention, there is provided a vector capable of expressing the DNA of the present invention adapted for expression in a recombinant cell and regulatory elements necessary for expression of the DNA in the cell.
In yet another embodiment of the present invention, there is provided a host cell transfected with the vector of the present invention, said vector expressing a RIGUI protein.
In still yet another embodiment of the present invention, there is provided a method of detecting expression of the protein of claim
1
, comprising the steps of: (a) contacting mRNA obtained from a cell with a labeled hybridization probe; and (b) detecting hybridization of the probe with the mRNA.
Other and further aspects, features, and advantages of the present invention will be apparent from the following description of the presently preferred embodiments of the invention given for the purpose of disclosure.
REFERENCES:
Tei, AB002107 Mar., 1997.
Tei, AB002108 Mar., 1997.
Citri et al., Nature 326:42-47 Mar., 1987.
Albrecht Urs
Eichele Gregor
Lee Cheng-Chi
Sun Zhong Sheng
Adler Benjamin Aaron
Carlson Karen Cochrane
Research Development Foundation
LandOfFree
Mammalian circadian rhythm-like gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mammalian circadian rhythm-like gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian circadian rhythm-like gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2589099